Dementia in X America

Dementia represents one of the most pressing public health challenges facing America today. As our population ages, the number of individuals affected by dementia is projected to rise dramatically, placing enormous strain on healthcare systems, families, and communities. This comprehensive national strategy aims to address the complex and multifaceted issues surrounding dementia in America, with a particular focus on the stark disparities in prevalence, diagnosis, and care among different racial, ethnic, and socioeconomic groups. The essay outlines the current impact of dementia, explores the factors driving health disparities, and proposes targeted interventions to improve public awareness, reduce stigma, and enhance early detection and diagnosis. By taking a holistic approach that considers the unique needs of diverse populations, this strategy seeks to create a more equitable, compassionate, and effective response to the growing dementia crisis in America.

Current Impact and Health Disparities

Dementia is a growing public health crisis in America, with significant impacts on individuals, families, healthcare systems, and society. As of 2025, over 6 million Americans are living with Alzheimer's disease, the most common form of dementia. This number is projected to more than double by 2050, placing an enormous strain on healthcare resources and caregivers (Maestre et al., 2024). Importantly, the burden of dementia is not equally distributed across the population. Significant disparities exist in dementia prevalence, diagnosis, and care among different racial and ethnic groups (Bofao et al., 2024).

African Americans are approximately twice as likely to develop Alzheimer's disease compared to non-Latinx whites. This significant disparity in Alzheimer's disease prevalence among African Americans is a major public health concern (Maestre et al., 2024). Several factors contribute to this increased risk, including higher rates of vascular risk factors such as hypertension and diabetes, which are known to increase the likelihood of developing Alzheimer's disease (Kirby et al., 2024). Additionally, socioeconomic factors, including lower levels of education and income, may play a role in this disparity. African Americans also face barriers to early diagnosis and treatment, often receiving diagnoses at later stages of the disease when cognitive impairment is more severe. This delay in diagnosis can lead to poorer health outcomes and increased healthcare costs (Jackson et al., 2024).

Latinx Americans are about 1.5 times more likely to develop Alzheimer's disease than non- Latinx whites. This elevated risk among Latinx Americans is attributed to a combination of genetic, environmental, and socioeconomic factors (Maestre et al., 2024). Like African Americans, Latinx Americans have higher rates of vascular risk factors, including diabetes and cardiovascular disease, which contribute to increased Alzheimer's risk (Kirby et al., 2024). Cultural factors, such as language barriers and differing perceptions of cognitive decline, may also impact timely diagnosis and treatment. Additionally, Latinx Americans often face challenges in accessing healthcare services, which can further exacerbate the disparity in Alzheimer's prevalence and outcomes (Bofao et al., 2024).

Native Americans and Alaska Natives have the second-highest prevalence of dementia after African Americans. This high prevalence of dementia among Native American and Alaska Native populations is a growing concern, particularly as these communities age (Maestre et al., 2024). Factors contributing to this elevated risk include higher rates of cardiovascular disease, diabetes, and other chronic health conditions. Limited access to healthcare services, especially in rural and remote areas, can lead to delayed diagnosis and treatment. Cultural beliefs and practices may also influence how dementia is perceived and managed within these communities. The lack of culturally appropriate screening tools and interventions further compounds the challenges in addressing dementia among Native Americans and Alaska Natives (Jackson et al., 2024).

Asian Americans have lower rates of dementia diagnosis, but this may be due to underdiagnosis rather than lower prevalence. The apparent lower prevalence of dementia among Asian Americans is a complex issue that requires careful consideration. While some studies suggest that Asian Americans may have a lower risk of developing Alzheimer's disease, there is growing evidence that underdiagnosis may be a significant factor in these statistics (Maestre et al., 2024). Cultural stigma surrounding cognitive decline and mental health issues can lead to reluctance in seeking medical attention for memory problems. Language barriers and lack of culturally appropriate screening tools may also contribute to underdiagnosis (Abuawad et al., 2024). Additionally, the Asian American population is highly diverse, with varying risk factors and genetic predispositions among different subgroups, making it crucial to conduct more targeted research to understand the true prevalence of dementia in this population (Ray et al., 2024).

Socioeconomic status and education levels

Socioeconomic status and education levels play a significant role in driving disparities in dementia prevalence and care. Individuals with lower socioeconomic status often have limited access to resources that can help maintain cognitive health throughout life, including reduced access to quality education, which has been linked to lower cognitive reserve and increased risk of dementia (Gore et al., 2023). Lower income levels can also lead to chronic stress, poor nutrition, and limited engagement in cognitively stimulating activities, all of which may contribute to higher dementia risk. Furthermore, those with lower education levels may have more difficulty understanding health information, navigating complex healthcare systems, and advocating for their health needs, potentially leading to delayed diagnosis and treatment of cognitive issues (Wiese et al., 2023).

Access to quality healthcare is a critical factor in the disparities observed in dementia care. Many underserved communities, particularly in urban and rural areas, face significant barriers to accessing specialized healthcare services, including memory clinics and neurologists (Wiese et al., 2023). This limited access can result in delayed diagnosis, inadequate management of comorbid conditions that increase dementia risk, and reduced opportunities for early intervention. Additionally, individuals from minority groups may experience discrimination or cultural insensitivity within the healthcare system, leading to mistrust and reluctance to seek medical care. The lack of diversity among healthcare providers can further exacerbate these issues, as patients may not have access to culturally competent care that addresses their specific needs and concerns (Aranda et al., 2023).

The prevalence of cardiovascular risk factors is another key driver of dementia disparities. Conditions such as hypertension, diabetes, and obesity are more common among certain racial and ethnic groups, particularly African Americans and Latinx Americans (Farina et al., 2024). These cardiovascular risk factors are strongly associated with an increased risk of both vascular dementia and Alzheimer's disease. The higher prevalence of these conditions in certain populations can be attributed to a combination of genetic factors, lifestyle habits, and limited access to preventive healthcare services. Managing these risk factors is crucial for reducing dementia risk, but disparities in healthcare access and health education can make it challenging for some groups to effectively control these conditions (Edelman, 2024).

Cultural beliefs and stigma surrounding cognitive decline significantly impact how different communities perceive and respond to dementia. In some cultures, cognitive decline may be viewed as a normal part of aging rather than a medical condition requiring intervention (Aranda et al., 2023). This perception can lead to delayed help-seeking behaviors and reduced engagement with healthcare services. Additionally, stigma associated with mental health issues and cognitive impairment can be particularly strong in certain communities, leading to social isolation of affected individuals and their caregivers. These cultural factors can result in underreporting of symptoms, resistance to formal diagnoses, and reluctance to participate in research studies, further perpetuating disparities in dementia care and understanding (Wiese et al., 2023).

Language barriers and lack of culturally appropriate care present significant challenges in addressing dementia disparities. For individuals with limited English proficiency, navigating the healthcare system and communicating effectively with providers can be extremely difficult (Yujin & Choi, 2020). This can lead to misunderstandings, misdiagnoses, and inadequate care. Moreover, many cognitive assessment tools and educational materials are not available in multiple languages or are not culturally adapted, potentially leading to inaccurate evaluations and ineffective interventions. The shortage of bilingual and culturally competent healthcare providers further compounds these issues, as patients may not receive care that is sensitive to their cultural background and specific needs (Aranda et al., 2023).

Rural populations face unique challenges in accessing dementia care services and support. These challenges are multifaceted and can significantly impact the quality of care received by individuals with dementia in rural areas. One of the primary issues is the shortage of healthcare providers, particularly specialists such as neurologists and geriatricians, in rural regions (Wiese et al., 2023). This shortage often necessitates long travel distances for consultations and follow-up care, which can be particularly burdensome for older adults with mobility issues or limited transportation options. Additionally, rural areas typically have fewer specialized memory care facilities and support services, limiting options for comprehensive dementia care. The lack of high-speed internet access in some rural areas can also hinder the use of telemedicine services, which could otherwise help bridge some of these gaps in care (Angelopoulou et al., 2022). Furthermore, rural communities may have limited resources for caregiver support and education, placing additional strain on families caring for individuals with dementia. These factors collectively contribute to delayed diagnoses, inadequate management of dementia symptoms, and reduced quality of life for both individuals with dementia and their caregivers in rural settings (Wiese et al., 2023).

National Dementia Strategy: Public Awareness and Understanding

Developing targeted, culturally sensitive awareness campaigns for diverse populations is a crucial component of enhancing public awareness and understanding of dementia. These campaigns should be tailored to address the specific needs, beliefs, and cultural contexts of different racial, ethnic, and socioeconomic groups (Hinton et al., 2024; Lee et al., 2023). For example, campaigns targeting African American communities might focus on the increased risk of Alzheimer's disease in this population and emphasize the importance of early detection and management of cardiovascular risk factors (Saiyasit et al., 2022). For Latinx communities, materials should be available in both English and Spanish, addressing cultural beliefs about aging and cognitive decline (Lassell et al., 2024). Asian American campaigns might focus on reducing stigma and encouraging open discussions about memory concerns within families (Ho et al., 2024; Sun et al., 2023). By creating culturally relevant content, these campaigns can more effectively reach and resonate with diverse populations, increasing the likelihood of engagement and behavior change.

Collaborating with community leaders and organizations to disseminate information is an essential strategy for increasing the reach and credibility of dementia awareness efforts. Community leaders, such as religious figures, local politicians, and respected elders, can serve as powerful advocates for dementia awareness and education (Wiese et al., 2023). Their endorsement can lend legitimacy to the campaign messages and encourage community members to take action. Partnering with local organizations, including cultural centers, senior centers, and health clinics, can provide valuable channels for distributing information and hosting educational events (Savold et al., 2023). These collaborations can also help identify and address specific barriers to dementia awareness and care within different communities. For example, working with a local mosque might reveal the need for dementia education materials that address Islamic perspectives on caregiving and end-of-life care.

Utilizing multiple communication channels, including social media and traditional media, is crucial for reaching a wide and diverse audience. While traditional media outlets such as television, radio, and print newspapers remain important, especially for older adults, social media platforms offer unique opportunities to engage younger generations and disseminate information quickly and widely (Malhotra et al., 2023). Platforms like Facebook can be used to share educational content and personal stories, while Twitter can be leveraged for quick facts and updates on dementia research. Instagram and TikTok can be particularly effective for reaching younger audiences with visually engaging content about brain health and dementia prevention (Batool et al., 2024). Additionally, partnering with popular podcasts or creating a dedicated dementia awareness podcast can provide in-depth discussions on various aspects of dementia. By employing a multi-channel approach, the campaign can ensure that information reaches people through their preferred media channels and in formats that resonate with different age groups and learning styles.

Incorporating personal stories and testimonials to humanize the dementia experience is a powerful way to increase empathy, reduce stigma, and motivate action. These narratives can come from individuals living with dementia, their family caregivers, healthcare providers, and researchers (Fletcher & Maddock, 2021). By sharing diverse stories that reflect the experiences of different communities, the campaign can help people see themselves and their loved ones in these narratives, making the issue more relatable and immediate. For example, featuring the story of a young-onset Alzheimer's patient can help dispel the myth that dementia only affects the elderly (Bermejo-Pareja & Teodoro, 2024). Sharing the experiences of a family navigating cultural expectations around caregiving can provide valuable insights and support to others in similar situations. These personal accounts can be presented through various formats, including written profiles, video interviews, and interactive online storytelling platforms. By putting a human face on dementia, these stories can inspire hope, encourage early diagnosis and intervention, and foster a more compassionate and supportive society for those affected by dementia (Livingston et al., 2024).

Reducing Stigma Associated with Cognitive Decline

Challenging misconceptions through education and open dialogue is a crucial step in reducing the stigma associated with cognitive decline and dementia. Many people hold inaccurate beliefs about dementia, such as the notion that it's a normal part of aging or that individuals with dementia are incapable of leading meaningful lives. To address these misconceptions, comprehensive educational programs should be developed and implemented across various settings, including schools, workplaces, and community centers (Wiese et al., 2023). These programs should provide accurate, up-to-date information about the causes, symptoms, and progression of dementia, as well as available treatments and support services. Open dialogue sessions, such as community forums or online discussion groups, can provide safe spaces for people to ask questions, share concerns, and learn from experts and those with lived experience (Joshi et al., 2024). By fostering a culture of open communication and continuous learning, we can gradually erode the myths and stereotypes that contribute to stigma.

Promoting positive images of individuals living with dementia is essential in reshaping public perceptions and attitudes. Too often, media portrayals of dementia focus on the late stages of the disease, reinforcing negative stereotypes and fear. Instead, awareness campaigns should highlight the full spectrum of experiences of people living with dementia, including those who continue to lead active, engaged lives in the early and middle stages of the condition (Kerwin et al., 2022). This can be achieved through various means, such as featuring success stories in media campaigns, showcasing artwork or other creative projects by individuals with dementia, and promoting books or films that offer nuanced, respectful portrayals of people living with cognitive decline. By emphasizing the humanity, dignity, and ongoing capabilities of individuals with dementia, we can help shift societal attitudes from fear and avoidance to understanding and inclusion.

Engaging celebrities and public figures to share personal experiences with dementia can significantly amplify the message of destigmatization. When well-known individuals speak openly about their own diagnoses or their experiences caring for loved ones with dementia, it helps to normalize conversations about cognitive decline and encourages others to seek help or support (Findley et al., 2023). These public figures can serve as powerful advocates, using their platforms to raise awareness, challenge stereotypes, and promote understanding. For example, a respected actor sharing their journey with early-onset Alzheimer's disease can help dispel myths about dementia only affecting the elderly. A prominent business leader discussing their role as a caregiver can highlight the impact of dementia on families and the importance of support systems. By leveraging the influence and reach of celebrities and public figures, we can bring dementia out of the shadows and into mainstream discourse, fostering greater empathy and support for those affected.

Supporting dementia-friendly community initiatives is a practical and impactful way to reduce stigma and improve the lives of individuals living with dementia and their caregivers. Dementia-friendly communities are designed to be inclusive, accessible, and supportive for people with cognitive impairments (Kim et al., 2023). This can involve a range of initiatives, such as training local businesses and service providers to better interact with and assist customers with dementia, creating clear signage and easy-to-navigate public spaces, and organizing social activities that are welcoming and accommodating to people with varying cognitive abilities. Libraries might offer dementia-friendly reading groups, while museums could develop sensory-rich exhibits that engage individuals with cognitive impairments. Local governments can play a crucial role by implementing policies that consider the needs of people with dementia in urban planning and public services (Ted Kheng et al., 2021). By fostering environments where people with dementia can remain active, engaged members of their communities, we not only improve their quality of life but also demonstrate to the broader public that individuals with cognitive decline can continue to be valuable contributors to society. This visibility and integration are key to breaking down barriers of misunderstanding and fear, ultimately reducing stigma and promoting a more inclusive society for all.

Improving Early Detection and Diagnosis

Implementing standardized cognitive screening protocols in primary care settings is a critical step in improving early detection and diagnosis of dementia. Primary care physicians are often the first point of contact for individuals experiencing cognitive changes, making these settings ideal for initial screenings (Rivasi et al., 2023; Zhao et al., 2024). Standardized protocols ensure that all patients receive consistent, evidence-based assessments, regardless of their healthcare provider or location. These protocols should include brief, validated cognitive screening tools that can be easily administered during routine check-ups. For example, the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA) could be incorporated into annual wellness visits for older adults (Untari et al., 2021; Jia et al., 2021). Additionally, electronic health records can be programmed to prompt physicians to conduct these screenings at appropriate intervals or when certain risk factors are present (Zeiler et al., 2025). By making cognitive screening a routine part of primary care, we can identify potential cognitive issues earlier, leading to timely interventions and better long-term outcomes for patients.

Developing and validating culturally appropriate assessment tools is essential for ensuring accurate and equitable dementia diagnosis across diverse populations. Many existing cognitive assessment tools were developed and validated primarily on white, English-speaking populations, which can lead to inaccurate results when used with individuals from different cultural or linguistic backgrounds (Zhao et al., 2024). To address this, researchers and clinicians must collaborate to create and validate assessment tools that take into account cultural differences in cognition, language, and educational background. This might involve adapting existing tools to include culturally relevant examples and references or developing entirely new assessments based on the cognitive constructs and cultural norms of specific populations (A Narrative Review of Alzheimer Dementia in African American and Hispanic Populations, 2024). These culturally appropriate tools should undergo rigorous validation studies to ensure their reliability and validity across different populations. By using more culturally sensitive assessment methods, healthcare providers can improve the accuracy of dementia diagnoses and reduce disparities in care.

Training healthcare providers in early detection and diagnosis of dementia is crucial for improving outcomes for patients with cognitive decline. Many healthcare professionals, particularly those in primary care settings, may lack specialized training in geriatrics or neurology, making it challenging for them to recognize the subtle early signs of dementia (Xu et al., 2024). Comprehensive training programs should be developed and implemented to address this gap. These programs should cover topics such as the different types of dementia, early warning signs, differential diagnosis, and appropriate use of cognitive assessment tools. Training should also include guidance on how to communicate effectively with patients and families about cognitive concerns and dementia diagnoses (Wollney et al., 2024). This can be particularly important when working with diverse populations, where cultural sensitivity is crucial (Robinson-Lane et al., 2024). Additionally, healthcare providers should be educated on the importance of ruling out reversible causes of cognitive decline, such as vitamin deficiencies or medication side effects (Araya et al., 2024). Ongoing professional development opportunities, such as workshops, online courses, and case-based learning modules, can help keep healthcare providers up-to-date with the latest advancements in dementia diagnosis and management. By enhancing the skills and knowledge of healthcare providers, we can ensure that more individuals receive timely and accurate diagnoses, leading to earlier interventions and better quality of life for those affected by dementia.

Increasing public awareness of early signs and symptoms of cognitive decline is a vital component of improving early detection and diagnosis of dementia. Many individuals and families may dismiss early symptoms of dementia as normal aging, leading to delays in seeking medical attention (Prathap et al., 2024). A comprehensive public awareness campaign should be developed to educate the general population about the difference between normal age-related changes in cognition and potential signs of dementia. This campaign should highlight early warning signs such as memory loss that disrupts daily life, challenges in planning or problem-solving, difficulty completing familiar tasks, confusion with time or place, and changes in mood or behavior (Zhao et al., 2025). Information should be disseminated through various channels, including social media, television and radio public service announcements, community workshops, and printed materials distributed in healthcare settings and community centers. The campaign should also emphasize the importance of early detection and the potential benefits of timely intervention, such as access to treatments that may slow disease progression and the opportunity to plan for future care needs (Ka et al., 2024). Additionally, efforts should be made to reach diverse communities with culturally appropriate messaging and materials in multiple languages (A Narrative Review of Alzheimer Dementia in African American and Hispanic Populations, 2024). By increasing public awareness, we can empower individuals and families to recognize potential cognitive issues earlier and seek appropriate medical evaluation, ultimately leading to earlier diagnoses and better outcomes for those affected by dementia.

Addressing dementia in America requires a coordinated, comprehensive, and culturally sensitive approach that recognizes the diverse needs of our population. This national strategy provides a roadmap for tackling the complex challenges posed by dementia, from improving public awareness and understanding to reducing stigma and enhancing early detection and diagnosis. By implementing targeted interventions that address health disparities, collaborating with community leaders, and leveraging multiple communication channels, we can work towards a future where all Americans have equal access to high-quality dementia care and support. The success of this strategy will depend on sustained commitment from policymakers, healthcare providers, researchers, and communities across the nation. As we move forward, it is crucial to continue monitoring progress, adapting our approaches based on new evidence, and maintaining a focus on equity and inclusion. By doing so, we can hope to mitigate the impact of dementia on individuals, families, and society as a whole, ultimately improving the lives of millions of Americans affected by this challenging condition.

References

Abuawad, M., Rjoub, A., Dumaidi, Y., Daraghma, M., Ghanim, M., Rabayaa, M., & Amer, J. (2024). Evaluation of knowledge and attitudes regarding Alzheimer's disease and related dementia among medical students in Palestine: A cross-sectional study. PLoS One, 19(5).?https://doi.org/10.1371/journal.pone.0304012

Alizadeh, N., Vahdat, K., Shashaani, S., Swann, J. L., & ?zaltιn, O.,Y. (2024). Risk score models for urinary tract infection hospitalization. PLoS One, 19(6).?https://doi.org/10.1371/journal.pone.0290215

Alzola, P., Carnero, C., Bermejo-Pareja, F., Sánchez-Benavides, G., Pe?a-Casanova, J., Puertas-Martín, V., Fernández-Calvo, B., & Contador, I. (2024). Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights. Journal of Clinical Medicine, 13(12), 3442.?https://doi.org/10.3390/jcm13123442

Angelopoulou, E., Papachristou, N., Bougea, A., Stanitsa, E., Kontaxopoulou, D., Fragkiadaki, S., Pavlou, D., Koros, C., De?irmenci, Y., Papatriantafyllou, J., Thireos, E., Politis, A., Tsouros, A., Bamidis, P., Stefanis, L., & Papageorgiou, S. (2022). How Telemedicine Can Improve the Quality of Care for Patients with Alzheimer's Disease and Related Dementias? A Narrative Review. Medicina, 58(12), 1705.?https://doi.org/10.3390/medicina58121705

Aranda, M. P., Marquez, D. X., Gallagher-Thompson, D., Pérez, A., Rojas, J. C., Hill, C. V., Reyes, Y., Dilworth-Anderson, P., & Portacolone, E. (2023). A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro-meso-macro perspective. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 9(2).?https://doi.org/10.1002/trc2.12389

Araya, D. A., Schindler, S. E., & Morris, J. C. (2024). Advances in blood biomarkers for Alzheimer disease (AD): A review. The Kaohsiung Journal of Medical Sciences, 40(8), 692-698.?https://doi.org/10.1002/kjm2.12870

Basnin, N., Mahmud, T., Islam, R. U., & Andersson, K. (2025). An Evolutionary Federated Learning Approach to Diagnose Alzheimer's Disease Under Uncertainty. Diagnostics, 15(1), 80.?https://doi.org/10.3390/diagnostics15010080

Batool, Z., Jamson, S., & Forward, S. (2024). Revealing How Much Drivers Understand about Vehicle Pollutants: Towards Development of Information Campaigns. Sustainability, 16(16), 7136.?https://doi.org/10.3390/su16167136

Bermejo-Pareja, F., & Teodoro, d. S. (2024). Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History. Journal of Clinical Medicine, 13(2), 536.?https://doi.org/10.3390/jcm13020536

Bofao, J., Zheng, A., & Sadarangani, T. (2024). Dementia-Related Disparities in Adult Day Centers: Results of a Bivariate Analysis. Journal of Gerontological Nursing, 50(4), 42-47.?https://doi.org/10.3928/00989134-20240313-01

Contador, I., Buch-Vicente, B., Teodoro, d. S., Llamas-Velasco, S., Villarejo-Galende, A., Benito-León, J., & Bermejo-Pareja, F. (2024). Charting Alzheimer's Disease and Dementia: Epidemiological Insights, Risk Factors and Prevention Pathways. Journal of Clinical Medicine, 13(14), 4100.?https://doi.org/10.3390/jcm13144100

Dotan, E., Lynch, S. M., Ryan, J. C., & Mitchell, E. P. (2024). Disparities in care of older adults of color with cancer: A narrative review. Cancer Medicine, 13(3).?https://doi.org/10.1002/cam4.6790

DuBose, L., Fan, Q., Fisher, L., Minh-Nguyet Hoang, Salha, D., Lee, S., Ory, M. G., & Falohun, T. (2024). Development and Evaluation of a Web-Based Platform for Personalized Educational and Professional Assistance for Dementia Caregivers: Proposal for a Mixed Methods Study. JMIR Research Protocols, 13.?https://doi.org/10.2196/64127

Edelman, S. (2024). Inadequate Insurance Coverage for Overweight/Obesity Management. The American Journal of Managed Care, 0.?https://www.proquest.com/scholarly-journals/inadequate-insurance-coverage-overweight-obesity/docview/3094678971/se-2

Farina, M. P., Crimmins, E. M., & Hayward, M. D. (2024). The role of Southern context in shaping life course exposures linked to dementia incidence for Black and White older adults in the United States. BMC Geriatrics, 24, 1-16.?https://doi.org/10.1186/s12877-024-05508-x

Findley, C. A., Cox, M. F., Lipson, A. B., Bradley, R., Hascup, K. N., Yuede, C., & Hascup, E. R. (2023). Health disparities in aging: Improving dementia care for Black women. Frontiers in Aging Neuroscience.?https://doi.org/10.3389/fnagi.2023.1107372?

Fisher, D. W., Dunn, J. T., & Dong, H. (2024). Distinguishing features of depression in dementia from primary psychiatric disease. Discover Mental Health, 4(1), 3.?https://doi.org/10.1007/s44192-023-00057-y

Fletcher, J. R., & Maddock, C. (2021). Dissonant dementia: neuropsychiatry, awareness, and contradictions in cognitive decline. Humanities & Social Sciences Communications, 8(1).?https://doi.org/10.1057/s41599-021-01004-4

Flieger, J., Forma, A., Flieger, W., Flieger, M., Gawlik, P. J., Eliasz Dzier?yński, Maciejewski, R., Teresiński, G., & Baj, J. (2024). Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease. International Journal of Molecular Sciences, 25(16), 8982.?https://doi.org/10.3390/ijms25168982

Gore, J., Denno, B., Omura, J. D., Baumgart, M., & McGuire, L. C. (2023). Promoting Healthy Aging to Reduce the Risk of Dementia: A Public Health Imperative. Generations Journal, 47(1), 1-11.?https://www.proquest.com/scholarly-journals/promoting-healthy-aging-reduce-risk-dementia/docview/2821056637/se-2

Higgins Tejera, C., Ware, E. B., Hicken, M. T., Kobayashi, L. C., Wang, H., Blostein, F., Zawistowski, M., Mukherjee, B., & Bakulski, K. M. (2024). The mediating role of systemic inflammation and moderating role of racialization in disparities in incident dementia. Communications Medicine, 4(1), 142.?https://doi.org/10.1038/s43856-024-00569-w

Hinton, L., Tran, D., Peak, K., Meyer, O. L., & Qui?ones, A. R. (2024). Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review. Alzheimer's & Dementia, 20(4), 3000-3020.?https://doi.org/10.1002/alz.13612

Ho, P., Yu, W. H., Tee, B. L., Lee, W., Li, C., Gu, Y., Yokoyama, J. S., Reyes‐Dumeyer, D., Choi, Y., Yang, H., Vardarajan, B. N., Tzuang, M., Lieu, K., Lu, A., Faber, K. M., Potter, Z. D., Revta, C., Kirsch, M., McCallum, J., . . . Wang, L. (2024). Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non‐genetic risk factors for Alzheimer's disease among Asian Americans and Canadians. Alzheimer's & Dementia, 20(3), 2058-2071.?https://doi.org/10.1002/alz.13611

Idiongo, O. U., dos Reis, H. J., & Antonio Carlos Pinheiro, d. O. (2024). Molecular Mechanisms Linking Osteoarthritis and Alzheimer's Disease: Shared Pathways, Mechanisms and Breakthrough Prospects. International Journal of Molecular Sciences, 25(5), 3044.?https://doi.org/10.3390/ijms25053044

Jackson, Y., Rhodus, E. K., & Harrington, N. G. (2024). 190 Translating Alzheimer's Disease Research to Improve Dementia Screening Through Health Message Design in the Community: A Qualitative Study. Journal of Clinical and Translational Science, 8, 57-58.?https://doi.org/10.1017/cts.2024.181

Jia, X., Wang, Z., Huang, F., Chang, S., Du, W., Jiang, H., Wang, H., Wang, J., Wang, F., Su, W., Xiao, H., Wang, Y., & Zhang, B. (2021). A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study. BMC Psychiatry, 21, 1-13.?https://doi.org/10.1186/s12888-021-03495-6

Joshi, P., Hendrie, K., Jester, D. J., Dasarathy, D., Lavretsky, H., Ku, B. S., Leutwyler, H., Torous, J., Jeste, D. V., & Tampi, R. R. (2024). Social connections as determinants of cognitive health and as targets for social interventions in persons with or at risk of Alzheimer's disease and related disorders: a scoping review. International Psychogeriatrics, 36(2), 92-118.?https://doi.org/10.1017/S1041610223000923

Ka, Y. K., Ki, Y. S., & Chang, K. (2024). Potential Exosome Biomarkers for Parkinson's Disease Diagnosis: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 25(10), 5307.?https://doi.org/10.3390/ijms25105307

Kazemeini, S., Nadeem-Tariq, A., Shih, R., Rafanan, J., Ghani, N., & Vida, T. A. (2024). From Plaques to Pathways in Alzheimer's Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis. International Journal of Molecular Sciences, 25(21), 11720.?https://doi.org/10.3390/ijms252111720

Kerwin, D., Abdelnour, C., Caramelli, P., Ogunniyi, A., Shi, J., Zetterberg, H., & Traber, M. (2022). Alzheimer's disease diagnosis and management: Perspectives from around the world. Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, 14(1).?https://doi.org/10.1002/dad2.12334

Kim, S., Yoon, H., & Jang, Y. (2023). Access to Primary Healthcare and Discussion of Memory Loss with a Healthcare Provider in Adults with Subjective Cognitive Decline: Does Race/Ethnicity Matter? Behavioral Sciences, 13(11), 955.?https://doi.org/10.3390/bs13110955

Kirby, A., Porter, T., Adewuyi, E. O., & Laws, S. M. (2024). Investigating Genetic Overlap between Alzheimer's Disease, Lipids, and Coronary Artery Disease: A Large-Scale Genome-Wide Cross Trait Analysis. International Journal of Molecular Sciences, 25(16), 8814.?https://doi.org/10.3390/ijms25168814

Kopel, J., Sehar, U., Choudhury, M., & Reddy, P. H. (2023). Alzheimer's Disease and Alzheimer's Disease-Related Dementias in African Americans: Focus on Caregivers. Healthcare, 11(6), 868.?https://doi.org/10.3390/healthcare11060868

Lassell, R. K. F., Tamayo, V., Pena, T. A., Kishi, M., Zwerling, J., Gitlin, L. N., & Brody, A. A. (2024). "When she goes out, she feels better:" co-designing a Green Activity Program with Hispanic/Latino people living with memory challenges and care partners. Frontiers in Aging Neuroscience.?https://doi.org/10.3389/fnagi.2024.1401255

Lee, H., Ha, H., Yim, S., Yang, H., Lee, V., Hong, E., Chow, T. W., Park, V. T., Li-San, W., Jun, G., & Choi, Y. (2023). Using community-based geographical information system (GIS) to recruit older Asian Americans in an Alzheimer's disease study. BMJ Open, 13(8).?https://doi.org/10.1136/bmjopen-2023-072761?

Li, X., Su, W., & Cai, L. (2025). A bibliometric analysis of research on dementia comorbid with depression from 2005 to 2024. Frontiers in Neuroscience.?https://doi.org/10.3389/fnins.2025.1508662

Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selb?k, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., Fox, N. C., Ferri, C. P., Gitlin, L. N., Howard, R., Kales, H. C., Kivim?ki, M., Larson, E. B., Nakasujja, N., Rockwood, K., . . . Mukadam, N. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet, 404(10452), 572-628. https://doi.org/10.1016/S0140-6736(24)01296-0

?

?